17.4% less compared to February 13: 10,451 patients with COVID-19 were hospitalized in Russia per day

In Russia, over the past day, 10,451 people were hospitalized with a diagnosis of coronavirus infection - 17.4% less than the day before (12,653).

According to the headquarters for the fight against COVID-19, the number of hospitalizations has decreased in 56 regions of the Russian Federation.

“The hospitalization rate for the past week per 100 thousand of the population was 76.5 and increased by 7% compared to the previous week,” the report says.

The daily increase in the number of patients with COVID-19 across the country amounted to 180,456 (on February 13, an indicator of 197,949 was recorded).

Most of the new cases were detected in St. Petersburg (11,384), Moscow (9,616) and the Moscow region (6,398).

Over the past day, 97,185 patients have fully recovered, 683 people have died.

The total number of coronavirus cases registered in Russia has reached 14,313,965.

The headquarters added that over the past week the incidence rate was 907.64 per 100 thousand of the population, an increase of 18.8%: “The increase in the incidence occurred in 74 regions of the Russian Federation, including in 33 regions an increase more than the national average” .

Andrey Vorobyov, Governor of the Moscow Region, said that the current wave of coronavirus infection is on the decline.

“A noticeable decline, I would say a radical decline, outpatient link.

It looks like another wave of coronavirus is ending.

We all hope that more will not come, God forbid.

This will allow us to work more rhythmically in other areas,” he said at a meeting with heads of districts and regional ministers.

More than 81% of Russians admitted to being tired from the COVID-19 pandemic.

This follows from the results of a survey by the Stopcoronavirus.rf portal conducted on social networks.

At the same time, at least 34% of respondents indicated the impact of the epidemiological situation on their mood.

In turn, over 38% of Russian citizens are tired of talking about coronavirus.

On February 14, it became known that scientists from the Central Research Institute of Epidemiology of Rospotrebnadzor had developed a coronavirus detector.

We are talking about a technology that allows us to detect SARS-CoV-2 at a minimum concentration, that is, at the earliest stages of the disease.

The invention is registered in Rospatent.

“In the context of a pandemic of a new coronavirus infection, test sensitivity and promptness in obtaining results are the most important characteristics of diagnostic systems.

The new development of TsNIIE fully meets these requirements,” the press release says.

According to one of the developers, Alexander Tyumentsev, head of the laboratory of experimental pharmacology of the Central Research Institute of Experimental Medicine, the proposed technology can become the basis of a system that allows you to quickly diagnose right at the bedside of a patient diagnosed with coronavirus infection.

This test system does not require high-tech equipment, the specialist noted.

"Sputnik Light"

A study conducted in Russia and Azerbaijan confirmed the safety of the combination of AstraZeneca and Sputnik Light vaccines.

This was reported by the press service of the Russian Direct Investment Fund.

“In studies involving 100 volunteers in Russia and 100 volunteers in Azerbaijan, the combination of drugs demonstrated an optimal safety and tolerability profile, which is consistent with the results of previous clinical studies on the safety of AstraZeneca, Sputnik V and Sputnik Light vaccines,” the statement says. message.

It is noted that the observation of volunteers was carried out for 57 days after the first vaccination.

During this period, there were no serious adverse events associated with vaccination.

“Preliminary data from the combined use of Sputnik Light and AstraZeneca vaccines confirm the correct use of different vaccines during revaccination.

In the context of the emergence of new dangerous strains of coronavirus, it is this approach that can provide safe, effective and long-term protection,” said RDIF CEO Kirill Dmitriev.

Earlier, AstraZeneca indicated that they would apply for registration in Russia of their vaccine against COVID-19 after receiving the test results.

At the same time, RDIF emphasized that Sputnik Light is an effective universal booster for AstraZeneca, Sinopharm, Moderna and Cansino vaccines.

The combination of the Russian one-component vaccine with other drugs after 14 days gives a greater immune response than when using one vaccine.